ATE401094T1 - Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist - Google Patents

Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist

Info

Publication number
ATE401094T1
ATE401094T1 AT00955489T AT00955489T ATE401094T1 AT E401094 T1 ATE401094 T1 AT E401094T1 AT 00955489 T AT00955489 T AT 00955489T AT 00955489 T AT00955489 T AT 00955489T AT E401094 T1 ATE401094 T1 AT E401094T1
Authority
AT
Austria
Prior art keywords
cancer cell
extract
ginkgo biloba
gkb
patient
Prior art date
Application number
AT00955489T
Other languages
English (en)
Inventor
Katy Drieu
Vassilios Papadopoulos
Original Assignee
Sod Conseils Rech Applic
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Univ Georgetown filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE401094T1 publication Critical patent/ATE401094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00955489T 1999-08-12 2000-08-11 Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist ATE401094T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14860499P 1999-08-12 1999-08-12

Publications (1)

Publication Number Publication Date
ATE401094T1 true ATE401094T1 (de) 2008-08-15

Family

ID=22526515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00955489T ATE401094T1 (de) 1999-08-12 2000-08-11 Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist

Country Status (11)

Country Link
EP (1) EP1200108B1 (de)
JP (2) JP2003507336A (de)
KR (1) KR20020060154A (de)
CN (1) CN1361697A (de)
AT (1) ATE401094T1 (de)
AU (1) AU6768900A (de)
CA (1) CA2378052C (de)
DE (1) DE60039517D1 (de)
ES (1) ES2307529T3 (de)
NO (1) NO20020666D0 (de)
WO (1) WO2001012208A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001277786A1 (en) * 2000-08-04 2002-02-18 Angiolab, Inc. Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase
EP1539095A1 (de) * 2002-08-27 2005-06-15 Société des Produits Nestlé S.A. Prävention oder behandlung von epithelgewebeschäden oder haarausfall
US7569236B2 (en) * 2003-10-10 2009-08-04 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
WO2005051406A1 (ja) * 2003-11-28 2005-06-09 Takara Bio Inc. セラミダーゼ阻害剤
KR20050081597A (ko) * 2004-02-16 2005-08-19 한국 메디텍 제약 주식회사 은행잎추출물을 유효성분으로 함유하는 발암억제효과를갖는 골다공증 치료제
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
DE102005062417A1 (de) 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
CN105833016A (zh) * 2016-05-26 2016-08-10 宋羽 一种治疗卵巢癌的中药组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
DE4105570A1 (de) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle Verwendung eines bakterien- und eiweissfreien filtrats
DE4208868A1 (de) * 1992-03-04 1993-09-09 Michaelis Peter Dr Med Verwendung eines arzneimittels zur behandlung von metastatischen krebserkrankungen
JPH07126180A (ja) * 1993-11-01 1995-05-16 Daicel Chem Ind Ltd 発癌抑制剤
JPH0977674A (ja) * 1995-07-07 1997-03-25 Kawashima Takaaki 薬用乾燥酵母含有機能性組成物
JPH09110713A (ja) * 1995-10-13 1997-04-28 Nippon Green Ueebu Kk グルタチオン−ｓ−トランスフェラーゼ活性化剤並びにそれを含む医薬品及び飲食物
JP2000505057A (ja) * 1995-11-09 2000-04-25 ソシエテ ドゥ コンソイユ ドゥ ルシェルシュ エ ダプリカシオン シオンティフィック エス．アー．（エス．セ．エール．アー．エス．） 膜発現の阻害を目的とするギンゴリド
JPH11209274A (ja) * 1998-01-22 1999-08-03 Bae O-Sung 疾病治療用喫煙物
US7267977B2 (en) * 1998-03-25 2007-09-11 Georgetown University Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer

Also Published As

Publication number Publication date
CA2378052C (en) 2010-03-23
JP2003507336A (ja) 2003-02-25
NO20020666L (no) 2002-02-11
KR20020060154A (ko) 2002-07-16
CA2378052A1 (en) 2001-02-22
EP1200108A1 (de) 2002-05-02
JP2007126472A (ja) 2007-05-24
DE60039517D1 (de) 2008-08-28
WO2001012208A1 (en) 2001-02-22
AU6768900A (en) 2001-03-13
ES2307529T3 (es) 2008-12-01
CN1361697A (zh) 2002-07-31
NO20020666D0 (no) 2002-02-11
EP1200108B1 (de) 2008-07-16

Similar Documents

Publication Publication Date Title
ATE286053T1 (de) Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2003089457A3 (en) Peptide inhibitors of protein kinase c ϝ for pain management
ATE469903T1 (de) Zur behandlung von krebserkrankungen geeignete pyrazolopyrimidine
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
WO2004043374A3 (en) Methods and compositions for treating cancer using proteasome inhibitors
WO2003087831A3 (en) Proteins involved in breast cancer
AU2003253877A1 (en) Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
WO2004048938A3 (en) Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
DE50010833D1 (de) Pharmazeutisches präparat enthaltend diamorphin und vitamin e seine verwendung zur behandlung der opiatsucht
GB9903762D0 (en) Organic compounds
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
UA84954C2 (ru) Конденсированные пиримидоны, пригодные для лечения и профилактики злокачественного новообразования
EP1147214A4 (de) Neues verfahren zum erschaffen von proteinkinase-inhibitoren
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
DE69911210D1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE401094T1 (de) Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist
ATE173620T1 (de) Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
IL149416A0 (en) Human enzymes of the metalloprotease family
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
MXPA02010759A (es) Derivados del acido (2-oxindol-3-ilidenil) acetico y su uso como inhibidores de la proteina quinasa.
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties